Results 201 to 210 of about 530,197 (354)
Three PtIV prodrugs MRP, DRP, and HRP are designed to induce pyroptosis in low GSDME‐expressing tumor cells via the Caspase‐3/GSDME pathway. By relaxing chromatin and reactivating GSDME, HRP can effectively induce pyroptosis, enhance pro‐inflammatory cytokine production, and exhibit potent antitumor effects.
Xinda Yang+10 more
wiley +1 more source
Bladder cancer biomarkers. [PDF]
Godlewski D+4 more
europepmc +1 more source
CLINICAL AND PATHOLOGICAL STUDIES ON RADICAL TOTAL CYSTECTOMY FOR URINARY BLADDER CANCER
Kiichi Suzuki+6 more
openalex +2 more sources
In this study, ferroptosis in colorectal cancer cells is induced by FK866 through the NAD⁺/STAT3/GPX4 pathway. To minimize systemic toxicity, a reactive oxygen species (ROS)‐responsive hydrogel is developed to co‐deliver FK866 and C188‐9, resulting in synergistic and localized antitumor effects.
Chenyang Ye+14 more
wiley +1 more source
Novel Strategies and Therapeutic Advances for Bladder Cancer. [PDF]
Ehrlich MI+4 more
europepmc +1 more source
Cigarette smoking and cancer of bladder and lung. [PDF]
Stanley Dische+3 more
openalex +1 more source
Astrocytic ET‐1 System Determines Microglia Phenotype Following Spinal Cord Injury
The study reveals that astrocytic ET‐1 system is solely activated by thrombin following SCI via RhoA/NF‐κB and MAPKs/NF‐κB signal pathway. The release of astrocytic ET‐1 drives microglia polarization toward M1 phenotype through YAP signaling via ETA and ETB receptors.
Bingqiang He+11 more
wiley +1 more source
Advancements in bladder cancer immunotherapy: a focus on intravesical approaches. [PDF]
Tang X, Yu T, Tong H, Wu Y.
europepmc +1 more source